Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Dev Biol. 2007 Aug 31;311(1):172–184. doi: 10.1016/j.ydbio.2007.08.044

Figure 3. Smad4-deficient NCCs have reduced Msx1/2 expression and a higher apoptotic rate.

Figure 3

(A,B) BrdU labeling showed similar proliferation index between control and mutant. (C,D) TUNEL assay showed an increased apoptotic rate in PA mesenchyme in mutant compared to the control. (E,F) Immunofluoresence staining revealed the β-galactosidase positive cells (NCCs) in PA mesenchyme. (G) No difference (p=0.94) was detected in the proliferation rate of NCCs in the PA-OFT region in control (23±11%) and in mutant (23±7%); Values are means ± SEM, n = 6. (H–O) RNA whole-mount in situ hybridization indicated the expression of both Msx1 and Msx2 were downregulated in the PA-OFT area in the mutant. J, K, N and O are higher magnification views of the PA-OFT area in H, I, L and M respectively.